Mission, KS, United States of America

Umar-Farouk Mamani

This inventor holds 1 USPTO granted patent. Top assignee: University of Missouri. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Umar-Farouk Mamani. Retrieved from https://idiyas.com/inventor/umar-farouk-mamani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Umar-Farouk Mamani

Introduction

Umar-Farouk Mamani is an accomplished inventor based in Mission, Kansas. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides for cancer treatment. His innovative work has the potential to impact cancer therapies significantly.

Latest Patents

Umar-Farouk Mamani holds a patent for "Polypeptides and compositions comprising the same." This patent includes polypeptides that can bind to the human PD-L1 protein, which plays a crucial role in cancer progression. The polypeptides developed by Mamani can block the PD-1/PD-L1 interaction, offering a promising method for treating cancer. He has 1 patent to his name.

Career Highlights

Mamani is affiliated with the University of Missouri, where he continues to advance his research in biotechnology. His work focuses on the therapeutic applications of polypeptides, showcasing his commitment to improving cancer treatment options.

Collaborations

Some of his notable coworkers include John Fetse and Hao Yu Liu. Their collaborative efforts contribute to the innovative research environment at the University of Missouri.

Conclusion

Umar-Farouk Mamani's contributions to the field of biotechnology, particularly in cancer treatment, highlight his role as a significant inventor. His work with polypeptides demonstrates the potential for innovative solutions in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…